SVC™ (Switching, Vacuum, Cooling) technology creates a less painful, safer, and more controlled treatment experience to benefit both practitioners and patients. Enabling the treatment of areas considered more difficult, such as the neck, décolleté and hands due to the reduction in pain, procedures utilizing SVC™ are suitable for all skin types, throughout the year.
SVC™ technology offers groundbreaking advances in the medical aesthetics industry. First, it gives physicians full control in changing the length and depth of the RF pulse, so treatments can be tailored to individual patients needs. A second feature, Smart Heat is generated before each pulse, improving the efficiency as lower energy levels can be used for precision treatments and better results.
SVC™ features a vacuum technology which ensures proper skin and tip coupling, while stretching the skin. Major benefits include the delivery of equal injury points, the elimination of epidermal burns, and the reduction of pain during treatments, as well as better handling for the practitioner, making it easier to achieve highly reproducible results. SVC™’s cooling feature utilizes advanced TEC technology to prevent burns, reduce pain, and speed up the recovery process. This protection allows for a safer, more comfortable treatment.
V-touch delivers unprecedented penetration depth control to physicians, allowing them to determine the desired biological response, all within one device. The ability to choose an ablative or coagulative solution via the use of one system gives practitioners a significant clinical advantage – the ability to customize their treatments according to patients specific needs.
SVC™ technology provides increased comfort for patients, both during and after treatments. The minimally invasive treatments deliver significantly less pain and reduced downtime, while patients receive outstanding clinical results. Additionally, the risk of PIH (post-inflammatory hyperpigmentation) is almost zero, making fractional RF treatments a much more attractive alternative to laser technologies for those patients on the Fitzpatrick scale who are more susceptible to suffering from PIH.
V-touch is pending FDA clearance.